Skyscape Web Viewer : Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management : Medication Index

View All
Factor IX
Factor VIII A.10. Why do patients with ESLD have abnormalities of hemostasis? A.3. What is the treatment for a patient with von Willebrand disease? A.8. Discuss the pathogenesis of preeclampsia. C.21. What concentrated factors and hemostatic agents are available for bleeding patients? C.6. What are the options to treat acquired hypofibrinogenemia?
Famotidine B.10. What preoperative medications, if any, would you give this patient? B.6. How should this patient be premedicated? C.8. What anesthetic agents would you use to induce and maintain general anesthesia in this patient?
Felbamate
Fenoldopam A.14. What is the mechanism of action of the major antihypertensive drugs? C.10. During the surgery, the blood pressure increases to 220/120 mm Hg. How would you treat the hypertension? C.4. What is the pathophysiology of aortic clamping and unclamping? C.8. Because this case involves an infrarenal aneurysm, is renal blood flow affected with placement of the cross-clamp? If an endovascular repair is chosen, what are the risks to the kidneys? Are there any treatment maneuvers that can be taken to minimize these risks in either repair?
Fentanyl
Ferrous sulfate
Fibrinogen concentrate C.10. If this patient had a massive blood loss, what blood replacement therapy would be indicated? C.21. What concentrated factors and hemostatic agents are available for bleeding patients? C.6. What are the options to treat acquired hypofibrinogenemia? C.9. Two hours later, estimated blood loss (EBL) is approximately 2 L and the patient has been resuscitated with 3 units of packed red blood cells (pRBCs), 229 mL intraoperative cell salvage (cell saver), and 500 mL albumin in addition to 4 L crystalloid. The surgeon says the field is still "oozy" and there is ongoing blood loss. What are your concerns for resuscitation moving forward? How will you guide your resuscitation? D.3. Describe the pathophysiology of potential complications following massive transfusion and hematologic resuscitation. What are the risks of thromboembolic complications after intraoperative administration of procoagulants?
Fletcher D.2. When will you wean the patient from the ventilator? D.3. What are the advantages and disadvantages of early tracheal extubation?
Fludrocortisone
Flumazenil C.16. What is your approach to emergence? What if the patient does not regain consciousness? C.3. How does the liver disease affect intraoperative medication management?
Fluoride A.5. If succinylcholine were the only NMBA used during the case and the patient did not exhibit a response to TOF stimulation, what is the likely diagnosis? How would you confirm it? C.6. How would you maintain anesthesia during the case?
Fluoxetine
Flurbiprofen
Fluvastatin
Folate
Furosemide